Graz, Austria

Felix Egger-Cimenti

This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostics Operations, Inc.. Active years: 2015.


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Felix Egger-Cimenti: Innovator in Sample Input Technology

Introduction

Felix Egger-Cimenti is a notable inventor based in Graz, Austria. He has made significant contributions to the field of medical technology, particularly in the area of sample input devices. His innovative approach has led to the development of a device that enhances the efficiency and accuracy of liquid sample transfers.

Latest Patents

Felix holds a patent for a "Sample input device for inputting liquid samples." This device is designed to transfer liquid samples, such as blood, from sample containers like syringes into analyzer devices. The invention includes retention elements that prevent particulate components from contaminating the analyzer. Additionally, it features a ventilation device that allows for proper air circulation during the sample transfer process.

Career Highlights

Felix is currently employed at Roche Diagnostics Operations, Inc., where he continues to work on innovative solutions in the diagnostics field. His role involves collaborating with other experts to enhance the functionality and reliability of medical devices.

Collaborations

Felix has worked alongside his coworker, Stefan Gulo, contributing to various projects aimed at improving medical technology. Their combined expertise has led to advancements in the efficiency of sample analysis.

Conclusion

Felix Egger-Cimenti's contributions to the field of medical technology through his innovative sample input device demonstrate his commitment to improving healthcare solutions. His work at Roche Diagnostics Operations, Inc. continues to impact the industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…